Request for Covid-19 Impact Assessment of this Report

Pharmaceuticals

Global Thrombin (Human) Market Growth 2022-2028

  • LP 4930375
  • 101 Pages
  • March 2022
  • Pharmaceuticals
Download Sample    Get Discount   
 
As the global economy mends, the 2021 growth of Thrombin (Human) will have significant change from previous year. According to our (LP Information) latest study, the global Thrombin (Human) market size is USD million in 2022 from USD 552.7 million in 2021, with a change of % between 2021 and 2022. The global Thrombin (Human) market size will reach USD 692.2 million in 2028, growing at a CAGR of 3.3% over the analysis period.

The United States Thrombin (Human) market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Thrombin (Human) market, reaching US$ million by the year 2028. As for the Europe Thrombin (Human) landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.

Global main Thrombin (Human) players cover Baxter, AMRESCO Inc, BD Biosciences, and Life Technologies Corporation, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.

This report presents a comprehensive overview, market shares, and growth opportunities of Thrombin (Human) market by product type, application, key manufacturers and key regions and countries.

Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6

500IU/Vial

1000IU/Vial

2500IU/Vial

Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.

Biotechnology

Medicine

Microbiology

Others

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.

Americas

United States

Canada

Mexico

Brazil

APAC

China

Japan

Korea

Southeast Asia

India

Australia

Europe

Germany

France

UK

Italy

Russia

Middle East & Africa

Egypt

South Africa

Israel

Turkey

GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include

Baxter

AMRESCO Inc

BD Biosciences

Life Technologies Corporation

PromoCell GmbH

Sigma-Aldrich Corporation

Vitrolife AB

CSL

Bayer

Grifols

Octapharma

Shanghai RAAS

Hualan Biological

1 Scope of the Report

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Thrombin (Human) Annual Sales 2017-2028

2.1.2 World Current & Future Analysis for Thrombin (Human) by Geographic Region, 2017, 2022 & 2028

2.1.3 World Current & Future Analysis for Thrombin (Human) by Country/Region, 2017, 2022 & 2028

2.2 Thrombin (Human) Segment by Type

2.2.1 500IU/Vial

2.2.2 1000IU/Vial

2.2.3 2500IU/Vial

2.3 Thrombin (Human) Sales by Type

2.3.1 Global Thrombin (Human) Sales Market Share by Type (2017-2022)

2.3.2 Global Thrombin (Human) Revenue and Market Share by Type (2017-2022)

2.3.3 Global Thrombin (Human) Sale Price by Type (2017-2022)

2.4 Thrombin (Human) Segment by Application

2.4.1 Biotechnology

2.4.2 Medicine

2.4.3 Microbiology

2.4.4 Others

2.5 Thrombin (Human) Sales by Application

2.5.1 Global Thrombin (Human) Sale Market Share by Application (2017-2022)

2.5.2 Global Thrombin (Human) Revenue and Market Share by Application (2017-2022)

2.5.3 Global Thrombin (Human) Sale Price by Application (2017-2022)

3 Global Thrombin (Human) by Company

3.1 Global Thrombin (Human) Breakdown Data by Company

3.1.1 Global Thrombin (Human) Annual Sales by Company (2020-2022)

3.1.2 Global Thrombin (Human) Sales Market Share by Company (2020-2022)

3.2 Global Thrombin (Human) Annual Revenue by Company (2020-2022)

3.2.1 Global Thrombin (Human) Revenue by Company (2020-2022)

3.2.2 Global Thrombin (Human) Revenue Market Share by Company (2020-2022)

3.3 Global Thrombin (Human) Sale Price by Company

3.4 Key Manufacturers Thrombin (Human) Producing Area Distribution, Sales Area, Product Type

3.4.1 Key Manufacturers Thrombin (Human) Product Location Distribution

3.4.2 Players Thrombin (Human) Products Offered

3.5 Market Concentration Rate Analysis

3.5.1 Competition Landscape Analysis

3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.6 New Products and Potential Entrants

3.7 Mergers & Acquisitions, Expansion

4 World Historic Review for Thrombin (Human) by Geographic Region

4.1 World Historic Thrombin (Human) Market Size by Geographic Region (2017-2022)

4.1.1 Global Thrombin (Human) Annual Sales by Geographic Region (2017-2022)

4.1.2 Global Thrombin (Human) Annual Revenue by Geographic Region

4.2 World Historic Thrombin (Human) Market Size by Country/Region (2017-2022)

4.2.1 Global Thrombin (Human) Annual Sales by Country/Region (2017-2022)

4.2.2 Global Thrombin (Human) Annual Revenue by Country/Region

4.3 Americas Thrombin (Human) Sales Growth

4.4 APAC Thrombin (Human) Sales Growth

4.5 Europe Thrombin (Human) Sales Growth

4.6 Middle East & Africa Thrombin (Human) Sales Growth

5 Americas

5.1 Americas Thrombin (Human) Sales by Country

5.1.1 Americas Thrombin (Human) Sales by Country (2017-2022)

5.1.2 Americas Thrombin (Human) Revenue by Country (2017-2022)

5.2 Americas Thrombin (Human) Sales by Type

5.3 Americas Thrombin (Human) Sales by Application

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Thrombin (Human) Sales by Region

6.1.1 APAC Thrombin (Human) Sales by Region (2017-2022)

6.1.2 APAC Thrombin (Human) Revenue by Region (2017-2022)

6.2 APAC Thrombin (Human) Sales by Type

6.3 APAC Thrombin (Human) Sales by Application

6.4 China

6.5 Japan

6.6 South Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

6.10 China Taiwan

7 Europe

7.1 Europe Thrombin (Human) by Country

7.1.1 Europe Thrombin (Human) Sales by Country (2017-2022)

7.1.2 Europe Thrombin (Human) Revenue by Country (2017-2022)

7.2 Europe Thrombin (Human) Sales by Type

7.3 Europe Thrombin (Human) Sales by Application

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Thrombin (Human) by Country

8.1.1 Middle East & Africa Thrombin (Human) Sales by Country (2017-2022)

8.1.2 Middle East & Africa Thrombin (Human) Revenue by Country (2017-2022)

8.2 Middle East & Africa Thrombin (Human) Sales by Type

8.3 Middle East & Africa Thrombin (Human) Sales by Application

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Manufacturing Cost Structure Analysis

10.1 Raw Material and Suppliers

10.2 Manufacturing Cost Structure Analysis of Thrombin (Human)

10.3 Manufacturing Process Analysis of Thrombin (Human)

10.4 Industry Chain Structure of Thrombin (Human)

11 Marketing, Distributors and Customer

11.1 Sales Channel

11.1.1 Direct Channels

11.1.2 Indirect Channels

11.2 Thrombin (Human) Distributors

11.3 Thrombin (Human) Customer

12 World Forecast Review for Thrombin (Human) by Geographic Region

12.1 Global Thrombin (Human) Market Size Forecast by Region

12.1.1 Global Thrombin (Human) Forecast by Region (2023-2028)

12.1.2 Global Thrombin (Human) Annual Revenue Forecast by Region (2023-2028)

12.2 Americas Forecast by Country

12.3 APAC Forecast by Region

12.4 Europe Forecast by Country

12.5 Middle East & Africa Forecast by Country

12.6 Global Thrombin (Human) Forecast by Type

12.7 Global Thrombin (Human) Forecast by Application

13 Key Players Analysis

13.1 Baxter

13.1.1 Baxter Company Information

13.1.2 Baxter Thrombin (Human) Product Offered

13.1.3 Baxter Thrombin (Human) Sales, Revenue, Price and Gross Margin (2020-2022)

13.1.4 Baxter Main Business Overview

13.1.5 Baxter Latest Developments

13.2 AMRESCO Inc

13.2.1 AMRESCO Inc Company Information

13.2.2 AMRESCO Inc Thrombin (Human) Product Offered

13.2.3 AMRESCO Inc Thrombin (Human) Sales, Revenue, Price and Gross Margin (2020-2022)

13.2.4 AMRESCO Inc Main Business Overview

13.2.5 AMRESCO Inc Latest Developments

13.3 BD Biosciences

13.3.1 BD Biosciences Company Information

13.3.2 BD Biosciences Thrombin (Human) Product Offered

13.3.3 BD Biosciences Thrombin (Human) Sales, Revenue, Price and Gross Margin (2020-2022)

13.3.4 BD Biosciences Main Business Overview

13.3.5 BD Biosciences Latest Developments

13.4 Life Technologies Corporation

13.4.1 Life Technologies Corporation Company Information

13.4.2 Life Technologies Corporation Thrombin (Human) Product Offered

13.4.3 Life Technologies Corporation Thrombin (Human) Sales, Revenue, Price and Gross Margin (2020-2022)

13.4.4 Life Technologies Corporation Main Business Overview

13.4.5 Life Technologies Corporation Latest Developments

13.5 PromoCell GmbH

13.5.1 PromoCell GmbH Company Information

13.5.2 PromoCell GmbH Thrombin (Human) Product Offered

13.5.3 PromoCell GmbH Thrombin (Human) Sales, Revenue, Price and Gross Margin (2020-2022)

13.5.4 PromoCell GmbH Main Business Overview

13.5.5 PromoCell GmbH Latest Developments

13.6 Sigma-Aldrich Corporation

13.6.1 Sigma-Aldrich Corporation Company Information

13.6.2 Sigma-Aldrich Corporation Thrombin (Human) Product Offered

13.6.3 Sigma-Aldrich Corporation Thrombin (Human) Sales, Revenue, Price and Gross Margin (2020-2022)

13.6.4 Sigma-Aldrich Corporation Main Business Overview

13.6.5 Sigma-Aldrich Corporation Latest Developments

13.7 Vitrolife AB

13.7.1 Vitrolife AB Company Information

13.7.2 Vitrolife AB Thrombin (Human) Product Offered

13.7.3 Vitrolife AB Thrombin (Human) Sales, Revenue, Price and Gross Margin (2020-2022)

13.7.4 Vitrolife AB Main Business Overview

13.7.5 Vitrolife AB Latest Developments

13.8 CSL

13.8.1 CSL Company Information

13.8.2 CSL Thrombin (Human) Product Offered

13.8.3 CSL Thrombin (Human) Sales, Revenue, Price and Gross Margin (2020-2022)

13.8.4 CSL Main Business Overview

13.8.5 CSL Latest Developments

13.9 Bayer

13.9.1 Bayer Company Information

13.9.2 Bayer Thrombin (Human) Product Offered

13.9.3 Bayer Thrombin (Human) Sales, Revenue, Price and Gross Margin (2020-2022)

13.9.4 Bayer Main Business Overview

13.9.5 Bayer Latest Developments

13.10 Grifols

13.10.1 Grifols Company Information

13.10.2 Grifols Thrombin (Human) Product Offered

13.10.3 Grifols Thrombin (Human) Sales, Revenue, Price and Gross Margin (2020-2022)

13.10.4 Grifols Main Business Overview

13.10.5 Grifols Latest Developments

13.11 Octapharma

13.11.1 Octapharma Company Information

13.11.2 Octapharma Thrombin (Human) Product Offered

13.11.3 Octapharma Thrombin (Human) Sales, Revenue, Price and Gross Margin (2020-2022)

13.11.4 Octapharma Main Business Overview

13.11.5 Octapharma Latest Developments

13.12 Shanghai RAAS

13.12.1 Shanghai RAAS Company Information

13.12.2 Shanghai RAAS Thrombin (Human) Product Offered

13.12.3 Shanghai RAAS Thrombin (Human) Sales, Revenue, Price and Gross Margin (2020-2022)

13.12.4 Shanghai RAAS Main Business Overview

13.12.5 Shanghai RAAS Latest Developments

13.13 Hualan Biological

13.13.1 Hualan Biological Company Information

13.13.2 Hualan Biological Thrombin (Human) Product Offered

13.13.3 Hualan Biological Thrombin (Human) Sales, Revenue, Price and Gross Margin (2020-2022)

13.13.4 Hualan Biological Main Business Overview

13.13.5 Hualan Biological Latest Developments

14 Research Findings and Conclusion

List of Tables

Table 1. Thrombin (Human) Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)

Table 2. Thrombin (Human) Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)

Table 3. Major Players of 500IU/Vial

Table 4. Major Players of 1000IU/Vial

Table 5. Major Players of 2500IU/Vial

Table 6. Global Thrombin (Human) Sales by Type (2017-2022) & (K Units)

Table 7. Global Thrombin (Human) Sales Market Share by Type (2017-2022)

Table 8. Global Thrombin (Human) Revenue by Type (2017-2022) & ($ million)

Table 9. Global Thrombin (Human) Revenue Market Share by Type (2017-2022)

Table 10. Global Thrombin (Human) Sale Price by Type (2017-2022) & (USD/Unit)

Table 11. Global Thrombin (Human) Sales by Application (2017-2022) & (K Units)

Table 12. Global Thrombin (Human) Sales Market Share by Application (2017-2022)

Table 13. Global Thrombin (Human) Revenue by Application (2017-2022)

Table 14. Global Thrombin (Human) Revenue Market Share by Application (2017-2022)

Table 15. Global Thrombin (Human) Sale Price by Application (2017-2022) & (USD/Unit)

Table 16. Global Thrombin (Human) Sales by Company (2020-2022) & (K Units)

Table 17. Global Thrombin (Human) Sales Market Share by Company (2020-2022)

Table 18. Global Thrombin (Human) Revenue by Company (2020-2022) ($ Millions)

Table 19. Global Thrombin (Human) Revenue Market Share by Company (2020-2022)

Table 20. Global Thrombin (Human) Sale Price by Company (2020-2022) & (USD/Unit)

Table 21. Key Manufacturers Thrombin (Human) Producing Area Distribution and Sales Area

Table 22. Players Thrombin (Human) Products Offered

Table 23. Thrombin (Human) Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 24. New Products and Potential Entrants

Table 25. Mergers & Acquisitions, Expansion

Table 26. Global Thrombin (Human) Sales by Geographic Region (2017-2022) & (K Units)

Table 27. Global Thrombin (Human) Sales Market Share Geographic Region (2017-2022)

Table 28. Global Thrombin (Human) Revenue by Geographic Region (2017-2022) & ($ millions)

Table 29. Global Thrombin (Human) Revenue Market Share by Geographic Region (2017-2022)

Table 30. Global Thrombin (Human) Sales by Country/Region (2017-2022) & (K Units)

Table 31. Global Thrombin (Human) Sales Market Share by Country/Region (2017-2022)

Table 32. Global Thrombin (Human) Revenue by Country/Region (2017-2022) & ($ millions)

Table 33. Global Thrombin (Human) Revenue Market Share by Country/Region (2017-2022)

Table 34. Americas Thrombin (Human) Sales by Country (2017-2022) & (K Units)

Table 35. Americas Thrombin (Human) Sales Market Share by Country (2017-2022)

Table 36. Americas Thrombin (Human) Revenue by Country (2017-2022) & ($ Millions)

Table 37. Americas Thrombin (Human) Revenue Market Share by Country (2017-2022)

Table 38. Americas Thrombin (Human) Sales by Type (2017-2022) & (K Units)

Table 39. Americas Thrombin (Human) Sales Market Share by Type (2017-2022)

Table 40. Americas Thrombin (Human) Sales by Application (2017-2022) & (K Units)

Table 41. Americas Thrombin (Human) Sales Market Share by Application (2017-2022)

Table 42. APAC Thrombin (Human) Sales by Region (2017-2022) & (K Units)

Table 43. APAC Thrombin (Human) Sales Market Share by Region (2017-2022)

Table 44. APAC Thrombin (Human) Revenue by Region (2017-2022) & ($ Millions)

Table 45. APAC Thrombin (Human) Revenue Market Share by Region (2017-2022)

Table 46. APAC Thrombin (Human) Sales by Type (2017-2022) & (K Units)

Table 47. APAC Thrombin (Human) Sales Market Share by Type (2017-2022)

Table 48. APAC Thrombin (Human) Sales by Application (2017-2022) & (K Units)

Table 49. APAC Thrombin (Human) Sales Market Share by Application (2017-2022)

Table 50. Europe Thrombin (Human) Sales by Country (2017-2022) & (K Units)

Table 51. Europe Thrombin (Human) Sales Market Share by Country (2017-2022)

Table 52. Europe Thrombin (Human) Revenue by Country (2017-2022) & ($ Millions)

Table 53. Europe Thrombin (Human) Revenue Market Share by Country (2017-2022)

Table 54. Europe Thrombin (Human) Sales by Type (2017-2022) & (K Units)

Table 55. Europe Thrombin (Human) Sales Market Share by Type (2017-2022)

Table 56. Europe Thrombin (Human) Sales by Application (2017-2022) & (K Units)

Table 57. Europe Thrombin (Human) Sales Market Share by Application (2017-2022)

Table 58. Middle East & Africa Thrombin (Human) Sales by Country (2017-2022) & (K Units)

Table 59. Middle East & Africa Thrombin (Human) Sales Market Share by Country (2017-2022)

Table 60. Middle East & Africa Thrombin (Human) Revenue by Country (2017-2022) & ($ Millions)

Table 61. Middle East & Africa Thrombin (Human) Revenue Market Share by Country (2017-2022)

Table 62. Middle East & Africa Thrombin (Human) Sales by Type (2017-2022) & (K Units)

Table 63. Middle East & Africa Thrombin (Human) Sales Market Share by Type (2017-2022)

Table 64. Middle East & Africa Thrombin (Human) Sales by Application (2017-2022) & (K Units)

Table 65. Middle East & Africa Thrombin (Human) Sales Market Share by Application (2017-2022)

Table 66. Key Market Drivers & Growth Opportunities of Thrombin (Human)

Table 67. Key Market Challenges & Risks of Thrombin (Human)

Table 68. Key Industry Trends of Thrombin (Human)

Table 69. Thrombin (Human) Raw Material

Table 70. Key Suppliers of Raw Materials

Table 71. Thrombin (Human) Distributors List

Table 72. Thrombin (Human) Customer List

Table 73. Global Thrombin (Human) Sales Forecast by Region (2023-2028) & (K Units)

Table 74. Global Thrombin (Human) Sales Market Forecast by Region

Table 75. Global Thrombin (Human) Revenue Forecast by Region (2023-2028) & ($ millions)

Table 76. Global Thrombin (Human) Revenue Market Share Forecast by Region (2023-2028)

Table 77. Americas Thrombin (Human) Sales Forecast by Country (2023-2028) & (K Units)

Table 78. Americas Thrombin (Human) Revenue Forecast by Country (2023-2028) & ($ millions)

Table 79. APAC Thrombin (Human) Sales Forecast by Region (2023-2028) & (K Units)

Table 80. APAC Thrombin (Human) Revenue Forecast by Region (2023-2028) & ($ millions)

Table 81. Europe Thrombin (Human) Sales Forecast by Country (2023-2028) & (K Units)

Table 82. Europe Thrombin (Human) Revenue Forecast by Country (2023-2028) & ($ millions)

Table 83. Middle East & Africa Thrombin (Human) Sales Forecast by Country (2023-2028) & (K Units)

Table 84. Middle East & Africa Thrombin (Human) Revenue Forecast by Country (2023-2028) & ($ millions)

Table 85. Global Thrombin (Human) Sales Forecast by Type (2023-2028) & (K Units)

Table 86. Global Thrombin (Human) Sales Market Share Forecast by Type (2023-2028)

Table 87. Global Thrombin (Human) Revenue Forecast by Type (2023-2028) & ($ Millions)

Table 88. Global Thrombin (Human) Revenue Market Share Forecast by Type (2023-2028)

Table 89. Global Thrombin (Human) Sales Forecast by Application (2023-2028) & (K Units)

Table 90. Global Thrombin (Human) Sales Market Share Forecast by Application (2023-2028)

Table 91. Global Thrombin (Human) Revenue Forecast by Application (2023-2028) & ($ Millions)

Table 92. Global Thrombin (Human) Revenue Market Share Forecast by Application (2023-2028)

Table 93. Baxter Basic Information, Thrombin (Human) Manufacturing Base, Sales Area and Its Competitors

Table 94. Baxter Thrombin (Human) Product Offered

Table 95. Baxter Thrombin (Human) Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 96. Baxter Main Business

Table 97. Baxter Latest Developments

Table 98. AMRESCO Inc Basic Information, Thrombin (Human) Manufacturing Base, Sales Area and Its Competitors

Table 99. AMRESCO Inc Thrombin (Human) Product Offered

Table 100. AMRESCO Inc Thrombin (Human) Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 101. AMRESCO Inc Main Business

Table 102. AMRESCO Inc Latest Developments

Table 103. BD Biosciences Basic Information, Thrombin (Human) Manufacturing Base, Sales Area and Its Competitors

Table 104. BD Biosciences Thrombin (Human) Product Offered

Table 105. BD Biosciences Thrombin (Human) Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 106. BD Biosciences Main Business

Table 107. BD Biosciences Latest Developments

Table 108. Life Technologies Corporation Basic Information, Thrombin (Human) Manufacturing Base, Sales Area and Its Competitors

Table 109. Life Technologies Corporation Thrombin (Human) Product Offered

Table 110. Life Technologies Corporation Thrombin (Human) Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 111. Life Technologies Corporation Main Business

Table 112. Life Technologies Corporation Latest Developments

Table 113. PromoCell GmbH Basic Information, Thrombin (Human) Manufacturing Base, Sales Area and Its Competitors

Table 114. PromoCell GmbH Thrombin (Human) Product Offered

Table 115. PromoCell GmbH Thrombin (Human) Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 116. PromoCell GmbH Main Business

Table 117. PromoCell GmbH Latest Developments

Table 118. Sigma-Aldrich Corporation Basic Information, Thrombin (Human) Manufacturing Base, Sales Area and Its Competitors

Table 119. Sigma-Aldrich Corporation Thrombin (Human) Product Offered

Table 120. Sigma-Aldrich Corporation Thrombin (Human) Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 121. Sigma-Aldrich Corporation Main Business

Table 122. Sigma-Aldrich Corporation Latest Developments

Table 123. Vitrolife AB Basic Information, Thrombin (Human) Manufacturing Base, Sales Area and Its Competitors

Table 124. Vitrolife AB Thrombin (Human) Product Offered

Table 125. Vitrolife AB Thrombin (Human) Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 126. Vitrolife AB Main Business

Table 127. Vitrolife AB Latest Developments

Table 128. CSL Basic Information, Thrombin (Human) Manufacturing Base, Sales Area and Its Competitors

Table 129. CSL Thrombin (Human) Product Offered

Table 130. CSL Thrombin (Human) Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 131. CSL Main Business

Table 132. CSL Latest Developments

Table 133. Bayer Basic Information, Thrombin (Human) Manufacturing Base, Sales Area and Its Competitors

Table 134. Bayer Thrombin (Human) Product Offered

Table 135. Bayer Thrombin (Human) Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 136. Bayer Main Business

Table 137. Bayer Latest Developments

Table 138. Grifols Basic Information, Thrombin (Human) Manufacturing Base, Sales Area and Its Competitors

Table 139. Grifols Thrombin (Human) Product Offered

Table 140. Grifols Thrombin (Human) Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 141. Grifols Main Business

Table 142. Grifols Latest Developments

Table 143. Octapharma Basic Information, Thrombin (Human) Manufacturing Base, Sales Area and Its Competitors

Table 144. Octapharma Thrombin (Human) Product Offered

Table 145. Octapharma Thrombin (Human) Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 146. Octapharma Main Business

Table 147. Octapharma Latest Developments

Table 148. Shanghai RAAS Basic Information, Thrombin (Human) Manufacturing Base, Sales Area and Its Competitors

Table 149. Shanghai RAAS Thrombin (Human) Product Offered

Table 150. Shanghai RAAS Thrombin (Human) Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 151. Shanghai RAAS Main Business

Table 152. Shanghai RAAS Latest Developments

Table 153. Hualan Biological Basic Information, Thrombin (Human) Manufacturing Base, Sales Area and Its Competitors

Table 154. Hualan Biological Thrombin (Human) Product Offered

Table 155. Hualan Biological Thrombin (Human) Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 156. Hualan Biological Main Business

Table 157. Hualan Biological Latest Developments

List of Figures

Figure 1. Picture of Thrombin (Human)

Figure 2. Thrombin (Human) Report Years Considered

Figure 3. Research Objectives

Figure 4. Research Methodology

Figure 5. Research Process and Data Source

Figure 6. Global Thrombin (Human) Sales Growth Rate 2017-2028 (K Units)

Figure 7. Global Thrombin (Human) Revenue Growth Rate 2017-2028 ($ Millions)

Figure 8. Thrombin (Human) Sales by Region (2021 & 2028) & ($ millions)

Figure 9. Product Picture of 500IU/Vial

Figure 10. Product Picture of 1000IU/Vial

Figure 11. Product Picture of 2500IU/Vial

Figure 12. Global Thrombin (Human) Sales Market Share by Type in 2021

Figure 13. Global Thrombin (Human) Revenue Market Share by Type (2017-2022)

Figure 14. Thrombin (Human) Consumed in Biotechnology

Figure 15. Global Thrombin (Human) Market: Biotechnology (2017-2022) & (K Units)

Figure 16. Thrombin (Human) Consumed in Medicine

Figure 17. Global Thrombin (Human) Market: Medicine (2017-2022) & (K Units)

Figure 18. Thrombin (Human) Consumed in Microbiology

Figure 19. Global Thrombin (Human) Market: Microbiology (2017-2022) & (K Units)

Figure 20. Thrombin (Human) Consumed in Others

Figure 21. Global Thrombin (Human) Market: Others (2017-2022) & (K Units)

Figure 22. Global Thrombin (Human) Sales Market Share by Application (2017-2022)

Figure 23. Global Thrombin (Human) Revenue Market Share by Application in 2021

Figure 24. Thrombin (Human) Revenue Market by Company in 2021 ($ Million)

Figure 25. Global Thrombin (Human) Revenue Market Share by Company in 2021

Figure 26. Global Thrombin (Human) Sales Market Share by Geographic Region (2017-2022)

Figure 27. Global Thrombin (Human) Revenue Market Share by Geographic Region in 2021

Figure 28. Global Thrombin (Human) Sales Market Share by Region (2017-2022)

Figure 29. Global Thrombin (Human) Revenue Market Share by Country/Region in 2021

Figure 30. Americas Thrombin (Human) Sales 2017-2022 (K Units)

Figure 31. Americas Thrombin (Human) Revenue 2017-2022 ($ Millions)

Figure 32. APAC Thrombin (Human) Sales 2017-2022 (K Units)

Figure 33. APAC Thrombin (Human) Revenue 2017-2022 ($ Millions)

Figure 34. Europe Thrombin (Human) Sales 2017-2022 (K Units)

Figure 35. Europe Thrombin (Human) Revenue 2017-2022 ($ Millions)

Figure 36. Middle East & Africa Thrombin (Human) Sales 2017-2022 (K Units)

Figure 37. Middle East & Africa Thrombin (Human) Revenue 2017-2022 ($ Millions)

Figure 38. Americas Thrombin (Human) Sales Market Share by Country in 2021

Figure 39. Americas Thrombin (Human) Revenue Market Share by Country in 2021

Figure 40. United States Thrombin (Human) Revenue Growth 2017-2022 ($ Millions)

Figure 41. Canada Thrombin (Human) Revenue Growth 2017-2022 ($ Millions)

Figure 42. Mexico Thrombin (Human) Revenue Growth 2017-2022 ($ Millions)

Figure 43. Brazil Thrombin (Human) Revenue Growth 2017-2022 ($ Millions)

Figure 44. APAC Thrombin (Human) Sales Market Share by Region in 2021

Figure 45. APAC Thrombin (Human) Revenue Market Share by Regions in 2021

Figure 46. China Thrombin (Human) Revenue Growth 2017-2022 ($ Millions)

Figure 47. Japan Thrombin (Human) Revenue Growth 2017-2022 ($ Millions)

Figure 48. South Korea Thrombin (Human) Revenue Growth 2017-2022 ($ Millions)

Figure 49. Southeast Asia Thrombin (Human) Revenue Growth 2017-2022 ($ Millions)

Figure 50. India Thrombin (Human) Revenue Growth 2017-2022 ($ Millions)

Figure 51. Australia Thrombin (Human) Revenue Growth 2017-2022 ($ Millions)

Figure 52. Europe Thrombin (Human) Sales Market Share by Country in 2021

Figure 53. Europe Thrombin (Human) Revenue Market Share by Country in 2021

Figure 54. Germany Thrombin (Human) Revenue Growth 2017-2022 ($ Millions)

Figure 55. France Thrombin (Human) Revenue Growth 2017-2022 ($ Millions)

Figure 56. UK Thrombin (Human) Revenue Growth 2017-2022 ($ Millions)

Figure 57. Italy Thrombin (Human) Revenue Growth 2017-2022 ($ Millions)

Figure 58. Russia Thrombin (Human) Revenue Growth 2017-2022 ($ Millions)

Figure 59. Middle East & Africa Thrombin (Human) Sales Market Share by Country in 2021

Figure 60. Middle East & Africa Thrombin (Human) Revenue Market Share by Country in 2021

Figure 61. Egypt Thrombin (Human) Revenue Growth 2017-2022 ($ Millions)

Figure 62. South Africa Thrombin (Human) Revenue Growth 2017-2022 ($ Millions)

Figure 63. Israel Thrombin (Human) Revenue Growth 2017-2022 ($ Millions)

Figure 64. Turkey Thrombin (Human) Revenue Growth 2017-2022 ($ Millions)

Figure 65. GCC Country Thrombin (Human) Revenue Growth 2017-2022 ($ Millions)

Figure 66. Manufacturing Cost Structure Analysis of Thrombin (Human) in 2021

Figure 67. Manufacturing Process Analysis of Thrombin (Human)

Figure 68. Industry Chain Structure of Thrombin (Human)

Figure 69. Channels of Distribution

Figure 70. Distributors Profiles

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Contact Us

+ 1-888-961-4454

Drop Us an email at

help@bigmarketresearch.com

Similar Reports

United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025

The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...

  • Publish Date: June 24, 2019
  • $1050
Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts

The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...

  • Publish Date: February 18, 2019
  • $1290
Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts

The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...

  • Publish Date: December 11, 2018
  • $1390